Metastasis-Directed Local Therapy of Hepatic Oligometastasis from Colorectal Cancer and Future Perspective in Radiation Therapy

키워드

참고문헌 (91)

1. Hellman S, "Oligometastases", J Clin Oncol, 13, pp.8~10 (1995)
2. Gadd MA, "Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma", Ann Surg, 218, pp.705~712 (1993)
3. Hughes KS, "Resection of the liver for colorectal carcinoma metastases : a multi-institutional study of patterns of recurrence", Surgery, 100, pp.278~284 (1986)
4. Nordlinger B, "Survival benefit of repeat liver resections for recurrent colorectal metastases : 143 cases. Association Francaise de Chirurgie", J Clin Oncol, 12, pp.1491~1496 (1994)
5. Yoshino T, "Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer : a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS", Ann Oncol, 29, pp.44~70 (2018)
6. 임채홍, "Role of Local Treatment for Oligometastasis: A Comparability Based Meta-Analysis", Cancer Research and Treatment, 54(4), pp.953~969 (2022), 대한암학회[DOI]
7. 유규상, "Prognostic factors in breast cancer with extracranial oligometastases and the appropriate role of radiation therapy", Radiation oncology journal, 33(4), pp.301~309 (2015), 대한방사선종양학회
8. Palma DA, "Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers : long-term results of the SABR-COMET phase II randomized trial", J Clin Oncol, 38, pp.2830~2838 (2020)
9. Nevens D, "Completeness of reporting oligometastatic disease characteristics in the literature and influence on oligometastatic disease classification using the ESTRO", EORTC nomenclature, 2022, pp.114, 587~595
10. Rao A, "Oligometastatic prostate cancer : a shrinking subset or an opportunity for cure?", Am Soc Clin Oncol Educ Book, 39, pp.309~320 (2019)
11. Guckenberger M, "Characterisation and classification of oligometastatic disease : a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation", Lancet Oncol, 21, pp.e18~28 (2020)
12. Lievens Y, "Defining oligometastatic disease from a radia-tion oncology perspective : an ESTRO-ASTRO consensus document", Radiother Oncol, 148, pp.157~166 (2020)
13. Xi Y, "Global colorectal cancer burden in 2020 and projections to 2040", Transl Oncol, 14, pp.101174~ (2021)
14. "Cancer stat facts: colorectal cancer" (2022)[URL]
15. Biller LH, "Diagnosis and treatment of metastatic colorectal cancer : a review", JAMA, 325, pp.669~685 (2021)
16. Siegel RL, "Cancer statistics, 2019", CA Cancer J Clin, 69, pp.7~34 (2019)
17. Riihimaki M, "Patterns of metastasis in colon and rectal cancer", Sci Rep, 6, pp.29765~ (2016)
18. 유진수, "Streamline flow of the portal vein affects the lobar distribution of colorectal liver metastases and has a clinical impact on survival", Annals of Surgical Treatment and Research, 92(5), pp.348~354 (2017), 대한외과학회
19. House MG, "Survival after hepatic resection for metastatic colorectal cancer : trends in outcomes for 1, 600 patients during two decades at a single institution", J Am Coll Surg, 210, pp.744~755 (2010)
20. Wei AC, "Survival after hepatic resection for colorectal metastases : a 10-year experience", Ann Surg Oncol, 13, pp.668~676 (2006)
21. Leal JN, "Time-to-surgery and survival outcomes in resectable colorectal liver metastases : a multi-institutional evaluation", J Am Coll Surg, 222, pp.766~779 (2016)
22. Valderrama-Trevino AI, "Hepatic metastasis from colorectal cancer", Euroasian J Hepatogastroenterol, 7, pp.166~175 (2017)
23. Hackl C, "Treatment of colorectal liver metastases in Germany : a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma", BMC Cancer, 14, pp.810~ (2014)
24. Van Cutsem E, "ESMO consensus guidelines for the management of patients with metastatic colorectal cancer", Ann Oncol, 27, pp.1386~1422 (2016)
25. Scorsetti M, "Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer", J Cancer Res Clin Oncol, 141, pp.543~553 (2015)
26. Rusthoven KE, "Multi-institutional phase I", II trial of stereotactic body radiation therapy for liver metastases, 2009, pp.27, 1572~1578
27. Hughes KS, "Resection of the liver for colorectal carcinoma metastases : a multi-institutional study of long-term survivors", Dis Colon Rectum, 31, pp.1~4 (1988)
28. Pawlik TM, "Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases", Ann Surg, 241, pp.715~722 (2005)
29. Bogach J, "Simultaneous versus staged resection for synchronous colorectal liver metastases : a population-based cohort study", Int J Surg, 74, pp.68~75 (2020)
30. Fong Y, "Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer : analysis of 1001 consecutive cases", Ann Surg, 230, pp.309~318 (1999)
31. Nordlinger B, "Surgical resection of colorectal carcinoma metastases to the liver : a prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie", Cancer, 77, pp.1254~1262 (1996)
32. Gawdi R, "Perioperative chemotherapy for resectable colorectal liver metastases : analysis from the Colorectal Operative Liver Metastases International Collaborative(COLOMIC)", J Surg Oncol, 126, pp.339~347 (2022)
33. Tomlinson JS, "Actual 10-year survival after resection of colorectal liver metastases defines cure", J Clin Oncol, 25, pp.4575~4580 (2007)
34. de Jong MC, "Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis : an international multi-institutional analysis of 1669 patients", Ann Surg, 250, pp.440~448 (2009)
35. Solbiati L, "Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer : long-term results in 117 patients", Radiology, 221, pp.159~166 (2001)
36. Curley SA, "Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies : results in 123 patients", Ann Surg, 230, pp.1~8 (1999)
37. Ruers T, "Local treatment of unresectable colorectal liver metastases : results of a randomized phase II trial", J Natl Cancer Inst, 109, pp.djx015~ (2017)
38. Otto G, "Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery", Ann Surg, 251, pp.796~803 (2010)
39. Kron P, "Ablation or resection for colorectal liver metastases? A systematic review of the literature", Front Oncol, 9, pp.1052~ (2019)
40. Gavriilidis P, "Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases : a systematic review and network meta-analysis", Hepatobiliary Pancreat Dis Int, 20, pp.307~314 (2021)
41. Wang LJ, "Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis : a propensity score analysis", World J Surg Oncol, 16, pp.207~ (2018)
42. Abdalla EK, "Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection", ablation for colorectal liver metastases, 2004, pp.239, 818~825
43. Aloia TA, "Solitary colorectal liver metastasis : resection determines outcome", Arch Surg, 141, pp.460~466 (2006)
44. White RR, "Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis", J Gastrointest Surg, 11, pp.256~263 (2007)
45. Gleisner AL, "Colorectal liver metastases : recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation", Arch Surg, 143, pp.1204~1212 (2008)
46. McKay A, "Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases", HPB Surg, 2009, pp.346863~ (2009)
47. Reuter NP, "Radiofrequency ablation vs. resection for hepatic colorectal metastasis : therapeutically equivalent?", J Gastrointest Surg, 13, pp.486~491 (2009)
48. 이관호, "대장암 간전이에 대한 절제술과 고주파 열치료의 비교", 대한소화기학회지, 59(3), pp.218~223 (2012), 대한소화기학회
49. Agcaoglu O, "Complementary use of resection and radiofrequency ablation for the treatment of colorectal liver metastases : an analysis of 395 patients", World J Surg, 37, pp.1333~1339 (2013)
50. Kim WW, "Comparison of hepatic resection and radiofrequency ablation for the treatment of colorectal liver metastasis", Indian J Surg, 77, pp.1126~1130 (2015)
51. Puijk RS, "Colorectal liver metastases : surgery versus thermal ablation(COLLISION)-a phase III single-blind prospective randomized controlled trial", BMC Cancer, 18, pp.821~ (2018)
52. "Comparison of hepatectomy and local ablation for resectable synchronous and metachronous colorectal liver metastasis (HELARC)" (2016)[URL]
53. Gurusamy K, "Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases(LAVA) : study protocol for a randomised controlled trial", Trials, 19, pp.105~ (2018)
54. Chang DT, "Stereotactic body radiotherapy for colorectal liver metastases : a pooled analysis", Cancer, 117, pp.4060~4069 (2011)
55. Kress MS, "Stereotactic body radiation therapy for liver metastases from colorectal cancer : analysis of safety, feasibility, and early outcomes", Front Oncol, 2, pp.8~ (2012)
56. Burkon P, "Stereotactic body radiation therapy for colorectal cancer liver metastases; early results", Klin Onkol, 25(Suppl 2), pp.2S93-7~ (2012)
57. McPartlin A, "Long-term outcomes of phase 1 and 2 studies of SBRT for hepatic colorectal metastases", Int J Radiat Oncol Biol Phys, 99, pp.388~395 (2017)
58. Joo JH, "Local control outcomes using stereotactic body radiation therapy for liver metastases from colorectal cancer", Int J Radiat Oncol Biol Phys, 99, pp.876~883 (2017)
59. Doi H, "Effect of primary tumor location and tumor size on the response to radiotherapy for liver metastases from colorectal cancer", Oncol Lett, 14, pp.453~460 (2017)
60. Barry A, "The management of colorectal cancer liver metastases : the radiation oncology viewpoint", Int J Radiat Oncol Biol Phys, 103, pp.540~541 (2019)
61. Kim YS, "Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma : analysis of prognostic factors", J Hepatol, 58, pp.89~97 (2013)
62. Goldberg SN, "Percutaneous radiofrequency tissue ablation : does perfusion-mediated tissue cooling limit coagulation necrosis?", J Vasc Interv Radiol, 9, pp.101~111 (1998)
63. Kim N, "Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma", J Hepatol, 73, pp.121~129 (2020)
64. Kang TW, "First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location : local control rate and risk of peritoneal seeding at long-term follow-up", Clin Radiol, 68, pp.e641~51 (2013)
65. Rim CH, "Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma : should they clash or reconcile?", Int J Radiat Biol, 97, pp.111~119 (2021)
66. "Radiofrequency ablation versus stereotactic radiotherapy in colorectal liver metastases (RAS01)" (2016)[URL]
67. 유제상, "Radiofrequency Ablation versus Stereotactic Body Radiation Therapy in the Treatment of Colorectal Cancer Liver Metastases", Cancer Research and Treatment, 54(3), pp.850~859 (2022), 대한암학회[DOI]
68. Franzese C, "Liver metastases from colorectal cancer : propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation", J Cancer Res Clin Oncol, 144, pp.1777~1783 (2018)
69. Stintzing S, "Percutaneous radiofrequency ablation(RFA)or robotic radiosurgery(RRS)for salvage treatment of colorectal liver metastases", Acta Oncol, 52, pp.971~977 (2013)
70. Vigano L, "Aggressive and multidisciplinary local approach to iterative recurrences of colorectal liver metastases", World J Surg, 42, pp.2651~2659 (2018)
71. Nieuwenhuizen S, "Thermal ablation versus stereotactic ablative body radiotherapy to treat unresectable colorectal liver metastases : a comparative analysis from the prospective Amsterdam CORE Registry", Cancers(Basel), 13, pp.4303~ (2021)
72. Gotohda N, "Clinical impact of radiofrequency ablation and stereotactic body radiation therapy for colorectal liver metastasis as local therapies for elderly, vulnerable patients", JGH Open, 4, pp.722~728 (2020)
73. Cheng JY, "Proton versus photon radiotherapy for primary hepatocellular carcinoma : a propensity-matched analysis", Radiat Oncol, 15, pp.159~ (2020)
74. Kim TH, "Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma : a randomized phase III trial", J Hepatol, 74, pp.603~612 (2021)
75. Hong TS, "Phase II study of proton-based stereotactic body radiation therapy for liver metastases : importance of tumor genotype", J Natl Cancer Inst, 109, pp.djx031~ (2017)
76. Kim K, "A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases", Radiother Oncol, 176, pp.9~16 (2022)
77. "Curative proton beam therapy for patients with liver metastasis of colorectal cancer" (2019)[URL]
78. Lee MT, "Phase I study of individualized stereotactic body radiotherapy of liver metastases", J Clin Oncol, 27, pp.1585~1591 (2009)
79. Oh D, "Potentially curative stereotactic body radiation therapy(SBRT)for single or oligometastasis to the lung", Acta Oncol, 51, pp.596~602 (2012)
80. Ahmed KA, "Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes after stereotactic body radiation therapy", Int J Radiat Oncol Biol Phys, 95, pp.1399~1404 (2016)
81. Anuja K, "Radiation-induced DNA damage response and resistance in colorectal cancer stem-like cells", Int J Radiat Biol, 95, pp.667~679 (2019)
82. Bardelli A, "PRL-3 expression in metastatic cancers", Clin Cancer Res, 9, pp.5607~5615 (2003)
83. Scott JG, "A genome-based model for adjusting radiotherapy dose(GARD) : a retrospective, cohort-based study", Lancet Oncol, 18, pp.202~211 (2017)
84. Andre T, "Pembrolizumab in microsatellite-instability-high advanced colorectal cancer", N Engl J Med, 383, pp.2207~2218 (2020)
85. Diaz LA Jr, "Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer(KEYNOTE-177) : final analysis of a randomised, open-label, phase 3 study", Lancet Oncol, 23, pp.659~670 (2022)
86. Alina M. Pevzner, "Abscopal effect in the radio and immunotherapy", Radiation oncology journal, 39(4), pp.247~253 (2021), 대한방사선종양학회[DOI]
87. Torok JA, "Combining immunotherapy and radiotherapy for the STAR treatment", Nat Rev Clin Oncol, 16, pp.666~667 (2019)
88. Ngwa W, "Using immunotherapy to boost the abscopal effect", Nat Rev Cancer, 18, pp.313~322 (2018)
89. Ebner DK, "Abscopal effect in recurrent colorectal cancer treated with carbon-ion radiation therapy : 2 case reports", Adv Radiat Oncol, 2, pp.333~338 (2017)
90. Ji D, "Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer", J Immunother Cancer, 8, pp.e000826~ (2020)
91. Parikh AR, "Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial", Nat Cancer, 2, pp.1124~1135 (2021)

관련 논문AI추천